key: cord-0971638-re0mt2tg
authors: Hirayama, Atsushi; Masui, Jun; Murayama, Ayumi; Fujita, Satomi; Okamoto, Jun; Tanaka, Jun; Hirayama, Takanori; Ohara, Toshitake; Hoffmann, Emma Nakagawa; Zhang, Jingwen; Kawachi, Haruna; Okuno, Hideo; Hamaguchi, Shigeto; Tomono, Kazunori; Asada, Rumiko
title: The characteristics and clinical course of patients with COVID-19 who received invasive mechanical ventilation in Osaka, Japan
date: 2020-10-27
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.10.051
sha: ab925d4982e624a7eaf5e71e864c6de45a943eab
doc_id: 971638
cord_uid: re0mt2tg

OBJECTIVE: To describe the detailed clinical course of patients with coronavirus disease 2019 (COVID-19) who received invasive mechanical ventilation. METHODS: We conducted a case series of patients with COVID-19 who received invasive mechanical ventilation in Osaka, Japan between January 29 and May 28, 2020. We described the patient characteristics and clinical course from onset. Additionally, we fitted logistic regression models to investigate the associations between patient characteristics and 30-day mortality rate. RESULTS: A total of 125 patients who received invasive mechanical ventilation (median age [IQR], 68 [57-73]; men, 77.6%) were enrolled. Overall, the 30-day mortality rate was 24.0%, and the median (IQR) length of ICU stay and length of invasive mechanical ventilation use were 16 (12-29) and 13 (9-26), respectively. From clinical onset, 121 (96.8%) patients were intubated within 14 days. In multivariable logistic regression analysis, aged ≥65 years (OR, 3.56; 95% CI, 1.21-10.49; P = 0.02) and male sex (OR, 3.75; 95% CI, 1.00-11.24, P = 0.04) were significantly associated with a higher 30-day mortality rate. CONCLUSIONS: In this case series of patients with COVID-19 who received invasive mechanical ventilation in Japan, the 30-day mortality rate was 24.0% and those aged ≥65 years and men were associated with higher 30-day mortality rate.

4 median (IQR) length of ICU stay and length of invasive mechanical ventilation use were 16 (12-29) and 13 (9-26), respectively. From clinical onset, 121 (96.8%) patients were intubated within 14 days. In multivariable logistic regression analysis, aged ≥65 years (OR, 3.56; 95% CI, 1.21-10.49; P=0.02) and male sex (OR, 3.75; 95% CI, 1.00-11.24, P=0.04) were significantly associated with a higher 30-day mortality rate.

In this case series of patients with COVID-19 who received invasive mechanical ventilation in Japan, the 30-day mortality rate was 24.0% and those aged ≥65 years and men were associated with higher 30-day mortality rate.

J o u r n a l P r e -p r o o f Introduction In Japan, the first laboratory-confirmed COVID-19 case was detected on January 16, 2020. Subsequently, the first case in Osaka was detected on January 29, 2020. On April 7, 2020, in response to the rapid spread of the COVID-19, the Japanese government declared a state of emergency [1] . Early studies have shown that 2-12% of patients required invasive mechanical ventilation, and the mortality rate of these patients was 26-97% [2] [3] [4] [5] [6] . However, detailed information such as 30-day mortality, interval range from clinical onset to intubation, or length of ICU stay, on patients with laboratory-confirmed COVID-19 who required invasive mechanical ventilation of earlier phase of COVID-19 outbreak in Japan is scarce.

J o u r n a l P r e -p r o o f

We conducted a retrospective observational study using data of active epidemiological investigation for COVID-19 which has been conducted under the Infectious Diseases Control Law [7] . According to the Guidelines for Epidemiological Studies established by the Ministry of Health, Labor, and Welfare of Japan, this study did not require approval from an ethics committee [8] . The detailed methods of the present study described in Supplemental Methods.

We identified all consecutive hospitalized patients with laboratory-confirmed COVID-19 who received invasive mechanical ventilation in Osaka from January 29 to April 28, 2020, and the last follow-up period was May 28, 2020. The primary outcome of this study was mortality rate after 30 days from the ICU hospitalization. We categorized age into four groups: aged <50 years, aged 50-64 years, aged 65-74 years, aged ≥75 years. The Kruskal-Wallis test and the Fisher's exact test were used to compare the variables across age categories. Univariable and multivariable logistic regression analyses were used to investigate the association between patient characteristics and 30-day mortality rate. All P-values were two-tailed, with P<0.05 considered statistically significant. All statistical analyses were performed using Stata/MP version 16.0 software (StataCorp, Lakeway Drive, Collage Station, TX).

As of April 28, 2020, a cumulative total of 1,553 patients with laboratory-confirmed COVID-19 were identified in Osaka, Japan. Of these, 125 patients ( Figure 1) . In multivariable logistic regression analysis, those aged ≥65 years (OR, 3.56; 95% CI, 1.21-10.49; P=0.02) and male sex (OR, 3.75; 95% CI, 1.00-11.24, P=0.04) were significantly associated with a higher 30-day mortality rate ( Earlier studies reported from other countries demonstrated that 26-97% of patients who received invasive mechanical ventilation died [2, [4] [5] [6] . These reported higher mortality rates were reflective of the different thresholds put in place for hospitalization by each country during the early stages of the outbreak. Although Japan also suffered from significant disarray during the study period, medical resources were strategically sourced in time to prevent severe disruption of the healthcare system in Osaka. We also uncovered the median interval range from clinical onset to intubation was 8 days, and 97% of patients were intubated within 14 days from clinical onset. In the case series of 21 critically ill patients in USA, the mean interval from clinical onset to hospitalization was 3.5 days, and 81% of those were admitted to the ICU less than 24 hours after hospitalization [9] . In a retrospective single-centered study from Shanghai demonstrated that 22 patients treated in the ICU were admitted 8.5 ± 4.0 days from clinical onset [10] . These findings supported our clinical implication that patients with laboratoryconfirmed COVID-19 should be carefully observed at least 14 days from clinical onset regardless of their symptoms.

Our study has several potential limitations. First, because the data was analyzed as of May 28, 2020, 22.4% of patients (28 out of 125) were still treated in the ICU. Second, we did J o u r n a l P r e -p r o o f not set common protocol of treatment, and our data lacked detailed information on in-hospital treatment (e.g., drug administrations, details of mechanical ventilation, adverse events occurred during treatment).Third, the number of PCR testing in Japan was fewer compared to other countries in the early phase of outbreak. Nevertheless, as the present study was a case series of patients who received invasive mechanical ventilation, the probability of misclassification should be low in this severe population.

In conclusion, the study of 125 laboratory-confirmed COVID-19 patients who received invasive mechanical ventilation, 97% of patients were intubated within 14 days from clinical onset, and the 30-day mortality rate was 24.0%. The present prefectural-level real-world evidence of Japan should facilitate preparedness against COVID-19.

Funding None.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. 

/seifunotorikumi_00003.html#1-3. Accessed on

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Risk factors associated with clinical outcomes in 323 COVID-19 hospitalized patients in Wuhan, China

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Baseline characteristics and outcomes of Italy

National Institute of Infectious Diseases. Guidelines for Active Epidemiological Investigation in Patients with Novel Coronavirus Infection (Tentative Version)

Ethical Guidelines for Medical and Health Research Involving Human Subjects

Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State

Clinical progression of patients with COVID-19 in Shanghai

We thank all of the stuff members of Osaka Prefectural Government and public health centers in Osaka for their efforts in collecting the data used in the study. We also thank all medical staff who treat patients with COVID-19 in Osaka prefecture.J o u r n a l P r e -p r o o f